Kowa Company
3-4-14 Nihonbashi-Honcho Chuo-ku
Tokyo
103
Tel: 81-0-3-32797780
Fax: 81-0-3-32415650
12 articles about Kowa Company
-
Nicox and Kowa Enter into Agreement for NCX 470 Development and Commercialization in Japan
2/8/2024
Nicox SA announced the signature of an agreement granting Kowa Company, Ltd., a Japanese company with a global pharmaceutical business engaged in ground-breaking research, development and marketing, exclusive Japanese rights to develop and commercialize NCX 470, Nicox’s nitric oxide (NO)-donating bimatoprost eye drop, for the lowering of intraocular pressure (IOP) in patients with glaucoma or ocular hypertension.
-
Gentronix Limited Signs First Japanese Contracted Screening Collaboration With Kowa Company
9/5/2012
-
Kowa Company Announces the Efficacy and Safety of a Novel Phosphodiesterase 3 Inhibitor K-134 for the Treatment of Intermittent Claudication in American Heart Association 2011
11/10/2011
-
Kowa Company Announces the Efficacy and Safety of a Novel Rho Kinase Inhibitor (K-115) in the Treatment of Glaucoma in Association for Research in Vision & Ophthalmology 2011
5/10/2011
-
Kowa Company Announces Peretinoin Reduces Recurrence Risk of Hepatocellular Carcinoma after Curative Therapy
9/13/2010
-
Eli Lilly and Company, Kowa Company and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
12/23/2009
-
Kowa Company: Study Demonstrates LIVALO(R) Is an Efficacious Treatment for Achieving Lipid Goals LIVALO Superior to Simvastatin in Reducing LDL-C When Comparing Starting Doses
10/22/2009
-
Kowa Company: LIVALO(R) Demonstrates Sustained, Long-Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
9/1/2009
-
Kowa Company Study Demonstrates Efficacy of Pitavastatin in Elderly Patients
6/16/2009
-
Teva Pharmaceutical Industries Limited (JOBS), Kowa Company to Partner in Generic Pharma Company in Japan; New Company Teva-Kowa Pharma Co.
9/24/2008
-
Kowa Company Acquires ProEthic Pharmaceuticals, Inc. New Company to be Called Kowa Pharmaceuticals America
8/4/2008
-
Nikken Chemicals Co., Ltd. To Become Wholly Owned Subsidiary Of Kowa Company In October
3/14/2006